Loading...

American Cannabis Company

OTCPK:AMMJ
Snowflake Description

Flawless balance sheet with weak fundamentals.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
AMMJ
OTCPK
$23M
Market Cap
  1. Home
  2. US
  3. Commercial Services
Company description

American Cannabis Company, Inc., together with its subsidiary, Hollister & Blacksmith, Inc., doing business as American Cannabis Consulting, provides solutions for businesses operating in the regulated cannabis industry in the United States and Canada. The last earnings update was 7 days ago. More info.


Add to Portfolio Compare Print
  • American Cannabis Company has significant price volatility in the past 3 months.
AMMJ Share Price and Events
7 Day Returns
3.1%
OTCPK:AMMJ
0.2%
US Professional Services
-0.3%
US Market
1 Year Returns
-56.5%
OTCPK:AMMJ
10.1%
US Professional Services
7%
US Market
AMMJ Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
American Cannabis Company (AMMJ) 3.1% -5.9% -7.4% -56.5% 117.5% -
US Professional Services 0.2% 4.3% 15% 10.1% 7.6% 16.5%
US Market -0.3% 2% 8.5% 7% 37.7% 46.8%
1 Year Return vs Industry and Market
  • AMMJ underperformed the Professional Services industry which returned 10.1% over the past year.
  • AMMJ underperformed the Market in United States of America which returned 7% over the past year.
Price Volatility
AMMJ
Industry
5yr Volatility vs Market

AMMJ Value

 Is American Cannabis Company undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for American Cannabis Company. This is due to cash flow or dividend data being unavailable. The share price is $0.435.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for American Cannabis Company's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are American Cannabis Company's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
OTCPK:AMMJ PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-12-31) in USD $-0.02
OTCPK:AMMJ Share Price ** OTCPK (2019-04-18) in USD $0.44
United States of America Professional Services Industry PE Ratio Median Figure of 37 Publicly-Listed Professional Services Companies 23.02x
United States of America Market PE Ratio Median Figure of 3,081 Publicly-Listed Companies 18.18x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of American Cannabis Company.

OTCPK:AMMJ PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= OTCPK:AMMJ Share Price ÷ EPS (both in USD)

= 0.44 ÷ -0.02

-23.55x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • American Cannabis Company is loss making, we can't compare its value to the US Professional Services industry average.
  • American Cannabis Company is loss making, we can't compare the value of its earnings to the United States of America market.
Price based on expected Growth
Does American Cannabis Company's expected growth come at a high price?
Raw Data
OTCPK:AMMJ PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -23.55x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
United States of America Professional Services Industry PEG Ratio Median Figure of 33 Publicly-Listed Professional Services Companies 1.68x
United States of America Market PEG Ratio Median Figure of 2,109 Publicly-Listed Companies 1.56x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for American Cannabis Company, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on American Cannabis Company's assets?
Raw Data
OTCPK:AMMJ PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-12-31) in USD $0.02
OTCPK:AMMJ Share Price * OTCPK (2019-04-18) in USD $0.44
United States of America Professional Services Industry PB Ratio Median Figure of 55 Publicly-Listed Professional Services Companies 2.3x
United States of America Market PB Ratio Median Figure of 5,184 Publicly-Listed Companies 1.91x
OTCPK:AMMJ PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= OTCPK:AMMJ Share Price ÷ Book Value per Share (both in USD)

= 0.44 ÷ 0.02

22.29x

* Primary Listing of American Cannabis Company.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • American Cannabis Company is overvalued based on assets compared to the US Professional Services industry average.
X
Value checks
We assess American Cannabis Company's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Professional Services industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Professional Services industry average (and greater than 0)? (1 check)
  5. American Cannabis Company has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

AMMJ Future Performance

 How is American Cannabis Company expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as American Cannabis Company has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
22.3%
Expected Professional Services industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is American Cannabis Company expected to grow at an attractive rate?
  • Unable to compare American Cannabis Company's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare American Cannabis Company's earnings growth to the United States of America market average as no estimate data is available.
  • Unable to compare American Cannabis Company's revenue growth to the United States of America market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
OTCPK:AMMJ Future Growth Rates Data Sources
Data Point Source Value (per year)
United States of America Professional Services Industry Earnings Growth Rate Market Cap Weighted Average 22.3%
United States of America Professional Services Industry Revenue Growth Rate Market Cap Weighted Average 5.2%
United States of America Market Earnings Growth Rate Market Cap Weighted Average 13.4%
United States of America Market Revenue Growth Rate Market Cap Weighted Average 7%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
OTCPK:AMMJ Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
OTCPK:AMMJ Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2018-12-31 1 -1 -1
2018-09-30 1 -1 -3
2018-06-30 1 0 -2
2018-03-31 2 0 -1
2017-12-31 2 0 -1
2017-09-30 3 0 0
2017-06-30 2 0 0
2017-03-31 2 0 -1
2016-12-31 2 -1 -1
2016-09-30 3 -1 0
2016-06-30 3 0 0
2016-03-31 3 0 0

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if American Cannabis Company is high growth as no earnings estimate data is available.
  • Unable to determine if American Cannabis Company is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
OTCPK:AMMJ Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from American Cannabis Company Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

OTCPK:AMMJ Past Financials Data
Date (Data in USD Millions) EPS *
2018-12-31 -0.02
2018-09-30 -0.05
2018-06-30 -0.04
2018-03-31 -0.03
2017-12-31 -0.03
2017-09-30 0.00
2017-06-30 -0.01
2017-03-31 -0.02
2016-12-31 -0.01
2016-09-30 -0.01
2016-06-30 -0.01
2016-03-31 -0.01

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if American Cannabis Company will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. Examine American Cannabis Company's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
  2. American Cannabis Company's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Commercial Services companies here
  3. While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access American Cannabis Company's filings and announcements here.
  4. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess American Cannabis Company's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
American Cannabis Company has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

AMMJ Past Performance

  How has American Cannabis Company performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare American Cannabis Company's growth in the last year to its industry (Professional Services).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • American Cannabis Company does not make a profit even though their year on year earnings growth rate was positive over the past 5 years.
  • Unable to compare American Cannabis Company's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare American Cannabis Company's 1-year growth to the US Professional Services industry average as it is not currently profitable.
Earnings and Revenue History
American Cannabis Company's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from American Cannabis Company Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

OTCPK:AMMJ Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-12-31 0.98 -0.95 1.24 0.00
2018-09-30 0.65 -2.51 1.60 0.00
2018-06-30 1.33 -1.99 1.57 0.00
2018-03-31 2.11 -1.45 1.75 0.00
2017-12-31 2.44 -1.49 2.13 0.00
2017-09-30 2.90 0.21 1.87 0.01
2017-06-30 2.15 -0.38 1.92 0.00
2017-03-31 1.64 -0.80 1.77 0.00
2016-12-31 1.56 -0.60 1.34 0.00
2016-09-30 2.77 -0.42 1.32 0.00
2016-06-30 2.87 -0.34 1.11 0.01
2016-03-31 2.90 -0.30 1.07 0.02
2015-12-31 2.80 -0.52 0.99 0.05
2015-09-30 1.90 -4.07 4.19 0.06
2015-06-30 2.03 -3.80 4.16 0.05
2015-03-31 1.67 -3.81 3.98 0.04
2014-12-31 1.26 -3.62 3.84 0.01
2014-09-30 0.68 0.01 0.31
2014-06-30 0.22 -0.07 0.18
2013-12-31 0.09 0.02 0.04

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if American Cannabis Company has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if American Cannabis Company has efficiently used its assets last year compared to the US Professional Services industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if American Cannabis Company improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess American Cannabis Company's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Professional Services industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
American Cannabis Company has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

AMMJ Health

 How is American Cannabis Company's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up American Cannabis Company's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • American Cannabis Company is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • American Cannabis Company has no long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of American Cannabis Company's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • American Cannabis Company has no debt, it does not need to be covered by short term assets.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from American Cannabis Company Company Filings, last reported 3 months ago.

OTCPK:AMMJ Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2018-12-31 1.01 0.00 1.09
2018-09-30 1.17 0.00 1.24
2018-06-30 1.33 0.00 1.30
2018-03-31 1.51 0.00 1.36
2017-12-31 0.78 0.00 1.65
2017-09-30 2.25 0.00 1.88
2017-06-30 1.78 0.00 1.68
2017-03-31 1.24 0.00 1.66
2016-12-31 0.65 0.00 0.75
2016-09-30 -0.14 0.15 0.07
2016-06-30 0.12 0.14 0.23
2016-03-31 0.13 0.07 0.28
2015-12-31 0.14 0.06 0.56
2015-09-30 0.17 0.05 0.49
2015-06-30 0.34 0.04 0.23
2015-03-31 0.34 0.03 0.32
2014-12-31 0.08 0.02 0.17
2014-09-30 0.04 0.09 0.16
2014-06-30 -0.09 0.22 0.31
2013-12-31 0.01 0.00 0.02
  • American Cannabis Company has no debt.
  • American Cannabis Company has no debt compared to 5 years ago when it was 15.4%.
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • American Cannabis Company has sufficient cash runway for 1.9 years based on current free cash flow.
  • American Cannabis Company has sufficient cash runway for 1.7 years if free cash flow continues to grow at historical rates of 39% each year.
X
Financial health checks
We assess American Cannabis Company's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. American Cannabis Company has a total score of 6/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

AMMJ Dividends

 What is American Cannabis Company's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from American Cannabis Company dividends.
If you bought $2,000 of American Cannabis Company shares you are expected to receive $0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate American Cannabis Company's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate American Cannabis Company's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
OTCPK:AMMJ Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
United States of America Professional Services Industry Average Dividend Yield Market Cap Weighted Average of 20 Stocks 1.5%
United States of America Market Average Dividend Yield Market Cap Weighted Average of 2009 Stocks 2.4%
United States of America Minimum Threshold Dividend Yield 10th Percentile 0.8%
United States of America Bottom 25% Dividend Yield 25th Percentile 1.4%
United States of America Top 25% Dividend Yield 75th Percentile 3.6%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as American Cannabis Company has not reported any payouts.
  • Unable to verify if American Cannabis Company's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of American Cannabis Company's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as American Cannabis Company has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess American Cannabis Company's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can American Cannabis Company afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. American Cannabis Company has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

AMMJ Management

 What is the CEO of American Cannabis Company's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Terry Buffalo
COMPENSATION $87,522
AGE 53
TENURE AS CEO 2.3 years
CEO Bio

Mr. Terry Buffalo serves as Principal Executive Officer at American Cannabis Company, Inc. and served as its Chief Executive Officer since January 4, 2017 and also served as its Chief Operations Officer from March 03, 2016 to January 01, 2017 and Consultant from February 02, 2016 to March 03, 2016. Mr. Buffalo has been a Director of American Cannabis Company, Inc. since June 1, 2017.

CEO Compensation
  • Terry's compensation has increased whilst company is loss making.
  • Terry's remuneration is lower than average for companies of similar size in United States of America.
Management Team Tenure

Average tenure and age of the American Cannabis Company management team in years:

1.5
Average Tenure
41
Average Age
  • The average tenure for the American Cannabis Company management team is less than 2 years, this suggests a new team.
Management Team

Ellis Smith

TITLE
Founder
COMPENSATION
$121K
AGE
41
TENURE
6.1 yrs

Terry Buffalo

TITLE
Principal Executive Officer & Director
COMPENSATION
$88K
AGE
53
TENURE
2.3 yrs

Tripp Keber

TITLE
Chief Executive Officer of Dixie Brands
COMPENSATION
$30K
AGE
49

Michael Schwanbeck

TITLE
Chief Financial Officer
AGE
26
TENURE
0.7 yrs

Tyler Schloesser

TITLE
Chief Operations Officer
AGE
27
TENURE
0.3 yrs
Board of Directors Tenure

Average tenure and age of the American Cannabis Company board of directors in years:

1.8
Average Tenure
53
Average Age
  • The average tenure for the American Cannabis Company board of directors is less than 3 years, this suggests a new board.
Board of Directors

Ellis Smith

TITLE
Founder
COMPENSATION
$121K
AGE
41
TENURE
1.9 yrs

Terry Buffalo

TITLE
Principal Executive Officer & Director
COMPENSATION
$88K
AGE
53
TENURE
1.8 yrs

Tad Mailander

TITLE
Director
AGE
62
TENURE
1.1 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price ($) Value ($)
X
Management checks
We assess American Cannabis Company's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. American Cannabis Company has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

AMMJ News

Simply Wall St News

AMMJ Company Info

Description

American Cannabis Company, Inc., together with its subsidiary, Hollister & Blacksmith, Inc., doing business as American Cannabis Consulting, provides solutions for businesses operating in the regulated cannabis industry in the United States and Canada. The company offers advisory and consulting services, including commercial cannabis business planning, cannabis business license application, cultivation build-out oversight, cannabis regulatory compliance, compliance audit, cannabis business growth strategy, and cannabis business monitoring services. It also sells products and equipment used in the cultivation, processing, transportation, or retail sale of cannabis, such as The Satchel, a pouch-like case designed as a child-proof exit package solution for the regulated cannabis industry; SoHum Living Soil, a just-add-water soil; High Density Racking System, which ensures that space is used in an efficient manner; The Cultivation Cube, a self-contained and scalable cultivation system; and other products for cultivation operations, medicinal and recreational cannabis dispensary operations, and infused-products. In addition, the company designs industry-specific products; and offers exclusive and non-exclusive customer products. American Cannabis Company, Inc. is headquartered in Denver, Colorado.

Details
Name: American Cannabis Company, Inc.
AMMJ
Exchange: OTCPK
Founded:
$22,621,205
52,002,772
Website: http://www.americancannabisconsulting.com
Address: American Cannabis Company, Inc.
5690 Logan Street,
Unit A,
Denver,
Colorado, 80216,
United States
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
OTCPK AMMJ New Common Stock Pink Sheets LLC US USD 30. Sep 2014
Number of employees
Current staff
Staff numbers
7
American Cannabis Company employees.
Industry
Research and Consulting Services
Commercial Services
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/04/22 00:26
End of day share price update: 2019/04/18 00:00
Last earnings filing: 2019/04/15
Last earnings reported: 2018/12/31
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.